Gala vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
54 providers verified independently·Independent researchHow we rank →

Short answer: Gala and Ro tie at 7.2/10 on our rubric, so the decision comes down to price and format rather than overall quality. Full reasoning, pricing and the cases where the other one wins are below.

Gala and Ro are tied at 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Ro is $149/mo membership + medication. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose Ro for users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

A side-by-side look at Gala and Ro to help you decide. We compare them on:

  • Starting price per month
  • Our overall score, out of 10
  • Medication type, brand-name or compounded
  • Whether they accept insurance
  • Who each one is best for

Gala

#30 of 54
7.2/10

Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.

Visit Gala

Ro

#33 of 54
7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside the Wegovy pen and pill, Zepbound, Ozempic, and Saxenda. Ro's Mounjaro page says it does not currently offer Mounjaro and points readers to Zepbound instead.

Visit Ro
FeatureGalaRo
Why each oneA free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling.
The most trusted name in telehealth with the fastest prescription turnaround, same-day approval is standard, not the exception.
Our Score7.2/107.2/10
Headline Pricefrom $149/mo$149/mo membership + medication
Medication TypeBothBrand
Insurance AcceptedNoYes
Best ForPatients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging
Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Watch out forBrand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
Ranking#30#33
Get startedVisit GalaVisit Ro

Pros & Cons Compared

Gala

Pros

  • +Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
  • +A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
  • +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
  • +All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

  • Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
  • Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
  • Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
  • Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
  • Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
  • Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

Ro

Pros

  • +Carries Foundayo (orforglipron), Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026, at $149 to $299 a month depending on dose on its pricing page
  • +Direct insurance billing with major carriers, with coverage, Wegovy or Zepbound can cost $0-25/mo copay
  • +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo prepaid annually, which its pricing page frames as a $900/year saving
  • +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx, some of the lowest cash brand prices available

Cons

  • Membership and medication are billed separately, readers need to add them together for the all-in monthly cost
  • Brand-name only, no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
  • Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

Gala and Ro are closely matched with identical scores of 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; Ro is $149/mo membership + medication. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Gala offers both brand-name and compounded medications, giving you more flexibility.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Gala and Ro start above the cheapest complete recurring program we track. Across all 54 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Try Gala

Headline price: from $149/mo

Visit Gala

Related comparisons

More head-to-head comparisons involving Gala and Ro.

Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is Gala legit and is Ro legit, with the verification evidence behind each answer.